TITLE:
Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients

CONDITION:
Asthma

INTERVENTION:
Qvar

SUMMARY:

      The primary objective of this study is to evaluate the effect of Beclomethasone dipropionate
      HFA on small airways compared to Fluticasone propionate powder for inhalation administered
      twice daily to poorly controlled asthmatics.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 12 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  Poorly controlled asthma;

          -  Average use of over 2 puffs of albuterol per day in the previous 7 days OR Having
             symptoms of asthma on 5 of the last 7 days OR Awakening at night due to asthma at
             least once in the previous 7 days OR Having been treated with a course of oral or
             intravenous steroids at least once in the last 3 months.

        Exclusion Criteria:

          -  Subjects receiving escalating doses of immunotherapy, oral immunotherapy or short
             course (rush) immunotherapy for rhinitis;

          -  Requires beta-blockers, MAO inhibitors, tricyclic antidepressants, oral or intranasal
             anticholinergics;

          -  History and/or presence of any non-asthmatic acute or chronic lung disease, including
             but not limited to bronchitis, emphysema, active tuberculosis, bronchiectasis or
             cystic fibrosis;

          -  History and/or presence of any clinically significant cardiovascular disease,
             clinically significant hepatic, renal, or endocrine dysfunction, stroke, uncontrolled
             diabetes, hyperthyroidism, convulsive disorders, neoplastic disease other than basal
             cell carcinoma, and significant psychiatric disease.
      
